InMed Pharmaceuticals (INM) Short Interest Ratio & Short Volume

$0.29

+0.01 (+3.59%)

(As of 07/26/2024 ET)

Compare

InMed Pharmaceuticals Short Interest Data

Current Short Interest: 136,700 shares
Previous Short Interest: 84,700 shares
Change Vs. Previous Month: +61.39%
Dollar Volume Sold Short: $36,457.89
Short Interest Ratio: 0.1 Days to Cover
Last Record Date: July 15, 2024

Outstanding Shares: 8,920,000 shares
Percentage of Shares Shorted: 1.53%
Today's Trading Volume: 3,260,285 shares
Average Trading Volume: 672,625 shares
Today's Volume Vs. Average: 485%

cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Short Selling InMed Pharmaceuticals ?

Sign up to receive the latest short interest report for InMed Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Short Interest Chart Days to Cover Chart Short Percent of Float Chart

INM Short Interest Over Time

INM Days to Cover Over Time

INM Percentage of Float Shorted Over Time

Ad Stansberry Research

Get out of cash before the Fed's next meeting

"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all $20,000 of his wife's 401k into shares of just ONE stock. Everyone on Wall Street said he was crazy. But a year later, that $20,000 in his wife's account was worth $120,000. Today, he says: "If you thought the dot-com mania was intense, what's about to happen in the coming weeks could be even crazier and could open up a new window of opportunity for 500%-plus gains."

Click here now to watch this exclusive interview

InMed Pharmaceuticals Short Interest History

Export to Excel

Report Date	Total Shares Sold Short	Dollar Volume Sold Short	Change from Previous Report	Percentage of Float Shorted	Days to Cover	Price on Report Date
7/15/2024	136,700 shares	$36,457.89	+61.4%	N/A	0.1	$0.27
6/30/2024	84,700 shares	$22,487.85	-43.5%	N/A	0.1	$0.27
6/15/2024	150,000 shares	$34,005.00	+252.9%	N/A	0.2	$0.23
5/31/2024	42,500 shares	$12,537.50	-44.6%	N/A	0.1	$0.30
5/15/2024	76,700 shares	$21,015.34	-78.6%	N/A	0.2	$0.27
4/30/2024	359,000 shares	$96,571.00	+213.5%	N/A	0.9	$0.27
Get the Latest News and Ratings for INM and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for InMed Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.
4/15/2024	114,500 shares	$36,491.15	+1,011.7%	N/A	0.3	$0.32
3/31/2024	10,300 shares	$3,749.20	-81.9%	N/A	0	$0.36
3/15/2024	57,000 shares	$20,520.00	-13.9%	N/A	0.3	$0.36
2/29/2024	66,200 shares	$27,473.00	-52.1%	N/A	0.3	$0.42
2/15/2024	138,300 shares	$47,990.10	+244.9%	N/A	0.7	$0.35
1/31/2024	40,100 shares	$14,431.99	-43.4%	N/A	0.2	$0.36
1/15/2024	70,800 shares	$27,081.00	-47.2%	N/A	0	$0.38
12/31/2023	134,000 shares	$55,744.00	+1,213.7%	N/A	0.1	$0.42
12/15/2023	10,200 shares	$3,672.00	-65.9%	N/A	0	$0.36
11/30/2023	29,900 shares	$13,156.00	+510.2%	N/A	0	$0.44
11/15/2023	4,900 shares	$1,989.40	-74.1%	N/A	0	$0.41
10/31/2023	18,900 shares	$9,143.82	+339.5%	N/A	0	$0.48
10/15/2023	4,300 shares	$2,743.40	+377.8%	N/A	0	$0.64
9/30/2023	900 shares	$629.91	-90.1%	N/A	0	$0.70
9/15/2023	9,100 shares	$7,683.13	-65.4%	N/A	0.2	$0.84
8/31/2023	26,300 shares	$21,592.30	+64.4%	N/A	0.5	$0.82
8/15/2023	16,000 shares	$14,961.60	-61.5%	N/A	0.2	$0.94
7/31/2023	41,500 shares	$46,480.00	+112.8%	N/A	0.5	$1.12
7/15/2023	19,500 shares	$18,721.95	+2.6%	N/A	0.2	$0.96
6/30/2023	19,000 shares	$17,480.00	-63.2%	N/A	0.2	$0.92
6/15/2023	51,600 shares	$65,532.00	+4.7%	N/A	0.4	$1.27
5/31/2023	49,300 shares	$66,062.00	-24.0%	N/A	0.1	$1.34
5/15/2023	64,900 shares	$75,284.00	-30.8%	N/A	0.1	$1.16
4/30/2023	93,800 shares	$112,560.00	-25.7%	N/A	0.2	$1.20
4/15/2023	126,300 shares	$157,875.00	+3.8%	N/A	0.2	$1.25
3/31/2023	121,700 shares	$131,436.00	-27.7%	N/A	0.2	$1.08
3/15/2023	168,400 shares	$178,504.00	+194.9%	N/A	0.2	$1.06
2/28/2023	57,100 shares	$75,943.00	-15.8%	N/A	0.1	$1.33
2/15/2023	67,800 shares	$113,226.00	-7.6%	N/A	0.1	$1.67
1/31/2023	73,400 shares	$135,056.00	-75.4%	N/A	0.1	$1.84
1/15/2023	297,800 shares	$562,842.00	+443.4%	3.8%	0.3	$1.89
12/30/2022	54,800 shares	$110,696.00	+13.0%	0.7%	0.1	$2.02
12/15/2022	48,500 shares	$90,210.00	+62.8%	0.6%	0.1	$1.86
11/30/2022	29,800 shares	$78,970.00	+223.9%	0.4%	0	$2.65
J.P. Morgan’s DIRE Warning (Ad) When the largest bank in the U.S. says a crisis is coming - you NEED to listen. The Wall Street Journal warns, "America's bonds are getting harder to sell." Click here to see why Wall Street is in PANIC mode >>>
11/15/2022	9,200 shares	$25,576.00	-32.9%	0.1%	0	$2.78
10/31/2022	13,700 shares	$41,785.00	+121.0%	0.2%	0	$3.05
10/15/2022	6,200 shares	$32,922.00	-83.9%	0.1%	0	$5.31
9/30/2022	38,600 shares	$254,516.82	-57.3%	0.5%	0	$6.59
9/15/2022	90,300 shares	$867,783.00	+12,800.0%	1.2%	0.1	$9.61
8/31/2022	700 shares	$4,165.00	-89.4%	N/A	0	$5.95
8/15/2022	6,600 shares	$2,571.36	-62.5%	0.1%	0	$0.39
7/31/2022	17,600 shares	$6,864.00	-18.9%	0.2%	0.1	$0.39
7/15/2022	21,700 shares	$8,029.00	+6.4%	0.3%	0.1	$0.37
6/30/2022	20,400 shares	$9,596.16	-80.1%	0.3%	0.1	$0.47
6/15/2022	102,300 shares	$53,400.60	+47.6%	1.3%	0.5	$0.52
5/31/2022	69,300 shares	$53,361.00	-29.4%	0.9%	0.3	$0.77
5/15/2022	98,100 shares	$81,423.00	-34.3%	1.3%	0.5	$0.83
4/30/2022	149,300 shares	$135,863.00	-8.7%	1.9%	0.7	$0.91
4/15/2022	163,600 shares	$142,806.44	+34.1%	2.1%	0.8	$0.87
3/31/2022	122,000 shares	$115,009.40	+114.4%	1.6%	0.9	$0.94
3/15/2022	56,900 shares	$41,024.90	-35.3%	0.7%	0.6	$0.72
2/28/2022	87,900 shares	$82,819.38	+2.6%	1.1%	0.8	$0.94
2/15/2022	85,700 shares	$99,412.00	-2.7%	1.1%	0.3	$1.16
1/31/2022	88,100 shares	$106,601.00	-15.7%	1.1%	0	$1.21
1/15/2022	104,500 shares	$129,580.00	+74.5%	1.3%	0	$1.24
12/31/2021	59,900 shares	$78,469.00	-8.4%	0.8%	0	$1.31
12/15/2021	65,400 shares	$96,792.00	-56.5%	0.8%	0	$1.48
11/30/2021	150,400 shares	$285,760.00	+69.9%	1.9%	0.1	$1.90
11/15/2021	88,500 shares	$118,590.00	-19.7%	1.1%	0	$1.34
10/29/2021	110,200 shares	$168,055.00	+69.3%	1.4%	0.2	$1.53
10/15/2021	65,100 shares	$91,140.00	-2.5%	0.8%	0.1	$1.40
9/30/2021	66,800 shares	$116,900.00	+189.2%	0.8%	0.3	$1.75
9/15/2021	23,100 shares	$47,553.66	+216.4%	0.3%	0.2	$2.06
8/31/2021	7,300 shares	$16,133.00	-92.4%	0.1%	0.1	$2.21
8/13/2021	96,600 shares	$231,840.00	-47.8%	1.2%	1.4	$2.40
7/30/2021	185,100 shares	$516,429.00	+98.2%	2.3%	2.6	$2.79
7/15/2021	93,400 shares	$249,378.00	+396.8%	1.2%	1.3	$2.67
6/30/2021	18,800 shares	$59,784.00	+37.2%	0.2%	0.2	$3.18
6/15/2021	13,700 shares	$39,045.00	-2.8%	0.2%	0.2	$2.85
5/28/2021	14,100 shares	$41,595.00	+30.6%	0.2%	0.2	$2.95
5/14/2021	10,800 shares	$30,348.00	-90.7%	0.1%	0.1	$2.81
4/30/2021	115,800 shares	$431,934.00	-14.7%	1.5%	0.7	$3.73
4/15/2021	135,800 shares	$435,918.00	-64.8%	1.7%	0.7	$3.21
3/31/2021	385,200 shares	$1.21 million	-6.6%	4.8%	1.8	$3.13
3/15/2021	412,600 shares	$1.96 million	+0.3%	5.2%	1.8	$4.75
2/26/2021	411,400 shares	$1.80 million	+7.3%	5.9%	1.7	$4.37
2/12/2021	383,500 shares	$2.05 million	+177.1%	5.5%	1.6	$5.35
1/29/2021	138,400 shares	$546,693.84	+63.2%	2.0%	0.6	$3.95
1/15/2021	84,800 shares	$367,184.00	No Change	1.2%	0.7	$4.33

INM Short Interest - Frequently Asked Questions

What is InMed Pharmaceuticals' current short interest?: Short interest is the volume of InMed Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of July 15th, investors have sold 136,700 shares of INM short. Learn More on InMed Pharmaceuticals' current short interest.
Is InMed Pharmaceuticals' short interest increasing or decreasing?: InMed Pharmaceuticals saw a increase in short interest in the month of July. As of July 15th, there was short interest totaling 136,700 shares, an increase of 61.4% from the previous total of 84,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.
How does InMed Pharmaceuticals' short interest compare to its competitors?: Here is how the short interest of companies in the industry of "pharmaceutical products" compare to InMed Pharmaceuticals: Kineta, Inc. (2.18%), Alterity Therapeutics Limited (0.21%), Shuttle Pharmaceuticals Holdings, Inc. (0.80%), TC Biopharm (Holdings) Plc (0.39%), Bionomics Limited (1.82%), GeoVax Labs, Inc. (5.29%), Alaunos Therapeutics, Inc. (9.66%), IM Cannabis Corp. (3.12%), Lixte Biotechnology Holdings, Inc. (0.67%), Hoth Therapeutics, Inc. (1.07%),
Which stocks are the most shorted right now?: As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.13 billion), Royal Caribbean Cruises Ltd. ($2.77 billion), Moderna, Inc. ($2.76 billion), Coinbase Global, Inc. ($2.36 billion), Rivian Automotive, Inc. ($2.22 billion), Paychex, Inc. ($2.02 billion), Tractor Supply ($1.81 billion), Enphase Energy, Inc. ($1.65 billion), Chesapeake Energy Co. ($1.62 billion), and Lululemon Athletica Inc. ($1.58 billion). View all of the most shorted stocks.

What does it mean to sell short InMed Pharmaceuticals stock?: Short selling INM is an investing strategy that aims to generate trading profit from InMed Pharmaceuticals as its price is falling. INM shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.
How does a short squeeze work against InMed Pharmaceuticals?: A short squeeze for InMed Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of INM, which in turn drives the price of the stock up even further.
How often is InMed Pharmaceuticals' short interest reported?: Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including INM, twice per month. The most recent reporting period available is July, 15 2024.